Annual report
6323.TEDINET S100TPT7
Period2023-03-01 → 2024-02-29
Filed2024-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100TJCI. Amended by S100TQUY (2024-06-24).
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥93.2bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥94.5bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥67.0bn | 2021-03-01 → 2022-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.8bn | 2020-03-01 → 2021-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥37.1bn | 2019-03-01 → 2020-02-29d | Cons. | Net sales (5-year summary) |
| Operating income | ¥24.1bn | 2023-03-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥26.4bn | 2022-03-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥27.1bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥30.3bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥17.8bn | 2021-03-01 → 2022-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.5bn | 2020-03-01 → 2021-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.5bn | 2019-03-01 → 2020-02-29d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥27.1bn | 2023-03-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥30.4bn | 2022-03-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥19.6bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.4bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.8bn | 2021-03-01 → 2022-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.5bn | 2020-03-01 → 2021-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.5bn | 2019-03-01 → 2020-02-29d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥20.1bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥22.7bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥156.1bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥126.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥88.3bn | at 2022-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥59.5bn | at 2021-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥54.8bn | at 2020-02-29d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥56.6bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥51.7bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥99.5bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥74.8bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥50.2bn | at 2022-02-28d | Cons. | Net assets |
| Net assets / equity | ¥34.6bn | at 2021-02-28d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥28.6bn | at 2020-02-29d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥38.0bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥28.3bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥38.0bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.3bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.6bn | at 2022-02-28d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.8bn | at 2021-02-28d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥12.8bn | at 2020-02-29d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥15.5bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.0bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.2bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.7bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.9bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.2bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥916m | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥792m | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥10.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.6bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.4bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥434m | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥1,111.11 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,237.42 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥742.1 | 2021-03-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥374.4 | 2020-03-01 → 2021-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥316.57 | 2019-03-01 → 2020-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥1,109.06 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥1,235.1 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥740.72 | 2021-03-01 → 2022-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥373.78 | 2020-03-01 → 2021-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥316.21 | 2019-03-01 → 2020-02-29d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥5,233.37 | at 2024-02-29 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,947.79 | at 2023-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,624.39 | at 2022-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,785.01 | at 2021-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,463.86 | at 2020-02-29d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 59.1% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.9% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.4% | at 2022-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.8% | at 2021-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.2% | at 2020-02-29d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 24.4% | 2023-03-01 → 2024-02-29 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 37.7% | 2022-03-01 → 2023-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 33.7% | 2021-03-01 → 2022-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.0% | 2020-03-01 → 2021-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.9% | 2019-03-01 → 2020-02-29d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,997 | at 2024-02-29 | Cons. | Number of employees |
| Employees | 4,372 | at 2023-02-28 | Cons. | Number of employees |
| Employees | 3,670 | at 2022-02-28d | Cons. | Number of employees |
| Employees | 2,473 | at 2021-02-28d | Cons. | Number of employees |
| Employees | 1,899 | at 2020-02-29d | Cons. | Number of employees |
| Revenue | ¥64.5bn | 2023-03-01 → 2024-02-29 | Standalone | Net sales |
| Revenue | ¥62.9bn | 2022-03-01 → 2023-02-28 | Standalone | Net sales |
| Revenue | ¥48.8bn | 2021-03-01 → 2022-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥27.1bn | 2020-03-01 → 2021-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥22.4bn | 2019-03-01 → 2020-02-29d | Standalone | Net sales (5-year summary) |
| Operating income | ¥16.7bn | 2023-03-01 → 2024-02-29 | Standalone | Operating income |
| Operating income | ¥12.4bn | 2022-03-01 → 2023-02-28 | Standalone | Operating income |
| Ordinary income | ¥18.8bn | 2023-03-01 → 2024-02-29 | Standalone | Ordinary income |
| Ordinary income | ¥13.9bn | 2022-03-01 → 2023-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥12.8bn | 2021-03-01 → 2022-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.1bn | 2020-03-01 → 2021-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.9bn | 2019-03-01 → 2020-02-29d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥18.8bn | 2023-03-01 → 2024-02-29 | Standalone | Income before income taxes |
| Profit before tax | ¥13.9bn | 2022-03-01 → 2023-02-28 | Standalone | Income before income taxes |
| Net income | ¥13.2bn | 2023-03-01 → 2024-02-29 | Standalone | Profit loss |
| Net income | ¥9.7bn | 2022-03-01 → 2023-02-28 | Standalone | Profit loss |
| Net income | ¥9.2bn | 2021-03-01 → 2022-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.1bn | 2020-03-01 → 2021-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.9bn | 2019-03-01 → 2020-02-29d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥96.0bn | at 2024-02-29 | Standalone | Assets |
| Total assets | ¥74.0bn | at 2023-02-28 | Standalone | Assets |
| Total assets | ¥55.2bn | at 2022-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥40.3bn | at 2021-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥36.9bn | at 2020-02-29d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥43.9bn | at 2024-02-29 | Standalone | Liabilities |
| Total liabilities | ¥36.7bn | at 2023-02-28 | Standalone | Liabilities |
| Net assets / equity | ¥52.2bn | at 2024-02-29 | Standalone | Net assets |
| Net assets / equity | ¥37.3bn | at 2023-02-28 | Standalone | Net assets |
| Net assets / equity | ¥28.8bn | at 2022-02-28d | Standalone | Net assets |
| Net assets / equity | ¥20.1bn | at 2021-02-28d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥17.4bn | at 2020-02-29d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥18.2bn | at 2024-02-29 | Standalone | Cash and deposits |
| Cash and deposits | ¥14.0bn | at 2023-02-28 | Standalone | Cash and deposits |
| EPS (basic) | ¥750.41 | 2023-03-01 → 2024-02-29 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥560.5 | 2022-03-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥533.66 | 2021-03-01 → 2022-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.67 | 2020-03-01 → 2021-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥225.93 | 2019-03-01 → 2020-02-29d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥749.03 | 2023-03-01 → 2024-02-29 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥559.45 | 2022-03-01 → 2023-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥532.67 | 2021-03-01 → 2022-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥181.37 | 2020-03-01 → 2021-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥225.68 | 2019-03-01 → 2020-02-29d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥135 | 2023-03-01 → 2024-02-29 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥135 | 2022-03-01 → 2023-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65 | 2021-03-01 → 2022-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-03-01 → 2021-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-03-01 → 2020-02-29d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,955.53 | at 2024-02-29 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,154.72 | at 2023-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,663.38 | at 2022-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,158 | at 2021-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,003.2 | at 2020-02-29d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 54.2% | at 2024-02-29 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.3% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.7% | at 2021-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.0% | at 2020-02-29d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 29.6% | 2023-03-01 → 2024-02-29 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 29.4% | 2022-03-01 → 2023-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 37.8% | 2021-03-01 → 2022-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.8% | 2020-03-01 → 2021-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.0% | 2019-03-01 → 2020-02-29d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 17,640,000 | at 2024-02-29 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2022-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2021-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2020-02-29d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 240 | at 2024-02-29 | Standalone | Number of employees |
| Employees | 229 | at 2023-02-28 | Standalone | Number of employees |
| Employees | 222 | at 2022-02-28d | Standalone | Number of employees |
| Employees | 218 | at 2021-02-28d | Standalone | Number of employees |
| Employees | 206 | at 2020-02-29d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 51
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2024-02-29 | −¥16m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2024-02-29 | −¥16m |
| Reconciling Itemsreconciling | segment assets | at 2024-02-29 | ¥18.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2024-02-29 | −¥596m |
| Life Sciencereportable segment | capex | 2023-03-01 → 2024-02-29 | ¥72m |
| Life Sciencereportable segment | depreciation | 2023-03-01 → 2024-02-29 | ¥35m |
| Life Sciencereportable segment | employees | at 2024-02-29 | 34 pure |
| Life Sciencereportable segment | revenue | 2023-03-01 → 2024-02-29 | ¥1.2bn |
| Life Sciencereportable segment | revenue external | 2023-03-01 → 2024-02-29 | ¥1.2bn |
| Life Sciencereportable segment | segment assets | at 2024-02-29 | ¥2.9bn |
| Life Sciencereportable segment | segment profit | 2023-03-01 → 2024-02-29 | ¥126m |
| Semiconductor And Flat Panel Displayreportable segment | capex | 2023-03-01 → 2024-02-29 | ¥1.5bn |
| Semiconductor And Flat Panel Displayreportable segment | depreciation | 2023-03-01 → 2024-02-29 | ¥2.5bn |
| Semiconductor And Flat Panel Displayreportable segment | employees | at 2024-02-29 | 3963 pure |
| Semiconductor And Flat Panel Displayreportable segment | revenue | 2023-03-01 → 2024-02-29 | ¥92.0bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue external | 2023-03-01 → 2024-02-29 | ¥92.0bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue intersegment | 2023-03-01 → 2024-02-29 | ¥16m |
| Semiconductor And Flat Panel Displayreportable segment | segment assets | at 2024-02-29 | ¥135.0bn |
| Semiconductor And Flat Panel Displayreportable segment | segment profit | 2023-03-01 → 2024-02-29 | ¥24.6bn |
| —segment total | capex | 2023-03-01 → 2024-02-29 | ¥1.6bn |
| —segment total | depreciation | 2023-03-01 → 2024-02-29 | ¥2.5bn |
| —segment total | revenue | 2023-03-01 → 2024-02-29 | ¥93.3bn |
| —segment total | revenue external | 2023-03-01 → 2024-02-29 | ¥93.2bn |
| —segment total | revenue intersegment | 2023-03-01 → 2024-02-29 | ¥16m |
| —segment total | segment assets | at 2024-02-29 | ¥137.9bn |
| —segment total | segment profit | 2023-03-01 → 2024-02-29 | ¥24.7bn |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2023-02-28 | −¥31m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2023-02-28 | −¥31m |
| Reconciling Itemsreconciling | segment assets | at 2023-02-28 | ¥14.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2023-02-28 | −¥494m |
| Life Sciencereportable segment | capex | 2022-03-01 → 2023-02-28 | ¥1.0bn |
| Life Sciencereportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥57m |
| Life Sciencereportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥1.2bn |
| Life Sciencereportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥1.2bn |
| Life Sciencereportable segment | segment assets | at 2023-02-28 | ¥2.6bn |
| Life Sciencereportable segment | segment profit | 2022-03-01 → 2023-02-28 | ¥89m |
| Semiconductor And Flat Panel Displayreportable segment | capex | 2022-03-01 → 2023-02-28 | ¥3.7bn |
| Semiconductor And Flat Panel Displayreportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥1.9bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥93.4bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥93.3bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥31m |
| Semiconductor And Flat Panel Displayreportable segment | segment assets | at 2023-02-28 | ¥109.9bn |
| Semiconductor And Flat Panel Displayreportable segment | segment profit | 2022-03-01 → 2023-02-28 | ¥26.8bn |
| —segment total | capex | 2022-03-01 → 2023-02-28 | ¥4.7bn |
| —segment total | depreciation | 2022-03-01 → 2023-02-28 | ¥2.0bn |
| —segment total | revenue | 2022-03-01 → 2023-02-28 | ¥94.5bn |
| —segment total | revenue external | 2022-03-01 → 2023-02-28 | ¥94.5bn |
| —segment total | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥31m |
| —segment total | segment assets | at 2023-02-28 | ¥112.5bn |
| —segment total | segment profit | 2022-03-01 → 2023-02-28 | ¥26.9bn |
| Semiconductor And Flat Panel Displayreportable segment | employees | at 2024-02-29 | 240 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,495
| Item | Context | Value | Unit |
|---|---|---|---|
| Treasury stock | CurrentYearInstant | -3000000 | JPY |
| Shareholders equity | Prior1YearInstant | 63619000000 | JPY |
| Shareholders equity | CurrentYearInstant | 84677000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 153000000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 292000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 4449000000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 7243000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 4602000000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 7535000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 85000000 | JPY |
| Subscription rights to shares | CurrentYearInstant | 85000000 | JPY |
| Non controlling interests | Prior1YearInstant | 6487000000 | JPY |
| Non controlling interests | CurrentYearInstant | 7251000000 | JPY |
| Net assets | Prior1YearInstant | 74795000000 | JPY |
| Net assets | CurrentYearInstant | 99550000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 126482000000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 156136000000 | JPY |
| Net sales | Prior1YearDuration | 94518000000 | JPY |
| Net sales | CurrentYearDuration | 93247000000 | JPY |
| Cost of sales | Prior1YearDuration | 59712000000 | JPY |
| Cost of sales | CurrentYearDuration | 57989000000 | JPY |
| Gross profit | Prior1YearDuration | 34806000000 | JPY |
| Gross profit | CurrentYearDuration | 35257000000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 8388000000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 11119000000 | JPY |
| Operating income | Prior1YearDuration | 26418000000 | JPY |
| Operating income | CurrentYearDuration | 24138000000 | JPY |
| Interest income noi | Prior1YearDuration | 19000000 | JPY |
| Interest income noi | CurrentYearDuration | 140000000 | JPY |
| Dividends income noi | Prior1YearDuration | 8000000 | JPY |
| Dividends income noi | CurrentYearDuration | 8000000 | JPY |
| Foreign exchange gains noi | Prior1YearDuration | 3948000000 | JPY |
| Foreign exchange gains noi | CurrentYearDuration | 2717000000 | JPY |
| Electricity sale income noi | Prior1YearDuration | 61000000 | JPY |
| Electricity sale income noi | CurrentYearDuration | 53000000 | JPY |
| House rent income noi | Prior1YearDuration | 34000000 | JPY |
| House rent income noi | CurrentYearDuration | 51000000 | JPY |
| Royalty income noi | Prior1YearDuration | 24000000 | JPY |
| Royalty income noi | CurrentYearDuration | 7000000 | JPY |
| Other noi | Prior1YearDuration | 217000000 | JPY |
| Other noi | CurrentYearDuration | 227000000 | JPY |
| Non operating income | Prior1YearDuration | 4315000000 | JPY |
| Non operating income | CurrentYearDuration | 3206000000 | JPY |
| Interest expenses noe | Prior1YearDuration | 49000000 | JPY |
| Interest expenses noe | CurrentYearDuration | 70000000 | JPY |
| Electricity sale expenses noe | Prior1YearDuration | 25000000 | JPY |
| Electricity sale expenses noe | CurrentYearDuration | 26000000 | JPY |
| Derivative expense noe | Prior1YearDuration | 289000000 | JPY |
| Derivative expense noe | CurrentYearDuration | 124000000 | JPY |
| Rent expenses noe | Prior1YearDuration | 8000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |